Back to 
STATE STREET CORP
STATE STREET CORP
SYREShowing 8 of 10 quarters
Position history for STATE STREET CORP's holdings in Spyre Therapeutics, Inc
STATE STREET CORP holds 3.1M shares of SYRE (Spyre Therapeutics, Inc), worth $271.4M as of 2026-Q2. The position was increased (+17.3% shares). SYRE represents 0.0% of STATE STREET CORP's portfolio.
Current Value
$271.4M
Current Shares
3.1M
Total Value Change
+$226.1M
Total Shares Change
+1.5M
Quarter-by-Quarter History
Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP